Hyperactive FOXA1 activates super-enhancer-engaged HIF2α/EPAS1 to promote endocrine-resistant metastatic ER-positive breast cancer

被引：0
|
作者：
Fu, Xiaoyong
Pereira, Resel
De Angelis, Carmine
Veeraraghavan, Jamunarani
Shea, Martin J.
Nanda, Sarmistha
Feng, Qin
Jeselsohn, Rinath
O'Malley, Bert W.
Brown, Myles
Osborne, C. Kent
Schiff, Rachel
机构：
[1] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-04-03
引用
收藏
页数：1
相关论文
共 15 条
  • [1] FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    De Angelis, Carmine
    Veeraraghavan, Jamunarani
    Nanda, Sarmistha
    Qin, Lanfang
    Cataldo, Maria L.
    Sethunath, Vidyalakshmi
    Mehravaran, Sepideh
    Gutierrez, Carolina
    Chamness, Gary C.
    Feng, Qin
    O'Malley, Bert W.
    Selenica, Pier
    Weigelt, Britta
    Reis-Filho, Jorge S.
    Cohen, Ofir
    Wagle, Nikhil
    Nardonek, Agostina
    Jeselsohn, Rinath
    Brown, Myles
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (52) : 26823 - 26834
  • [2] AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
    Zhou, Meng
    Gan, Xing-li
    Ren, Yue-xiang
    Chen, Qian-xin
    Yang, Yuan-zhong
    Weng, Zi-jin
    Zhang, Xiao-fang
    Guan, Jie-xia
    Tang, Lu-ying
    Ren, Ze-fang
    BMC CANCER, 2023, 23 (01)
  • [3] AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
    Meng Zhou
    Xing-li Gan
    Yue-xiang Ren
    Qian-xin Chen
    Yuan-zhong Yang
    Zi-jin Weng
    Xiao-fang Zhang
    Jie-xia Guan
    Lu-ying Tang
    Ze-fang Ren
    BMC Cancer, 23
  • [4] High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    Liu, Chia -Chia
    De Angelis, Carmine
    Shea, Martin J.
    Nanda, Sarmistha
    Qin, Lanfang
    Mitchell, Tamika
    Cataldo, Maria L.
    Veeraraghavan, Jamunarani
    Sethunath, Vidyalakshmi
    Giuliano, Mario
    Gutierrez, Carolina
    Gyorffy, Balazs
    Trivedi, Meghana, V
    Cohen, Ofir
    Wagle, Nikhil
    Nardone, Agostina
    Jeselsohn, Rinath
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    CELL REPORTS, 2023, 42 (08):
  • [5] FOXA1 induces a pro-metastatic secretome through ER-dependent and independent transcriptional reprogramming in endocrine-resistant breast cancer
    Fu, X.
    Pereira, R.
    Zhao, D.
    Jung, S. Y.
    Jeselsohn, R.
    Creighton, C. J.
    Shea, M.
    Nardone, A.
    Angelis, C. D.
    Tsimelzon, A.
    Wang, T.
    Gutierrez, C.
    Huang, S.
    Edwards, D. P.
    Rimawi, M. F.
    Hilsenbeck, S. G.
    Brown, M.
    Chen, K.
    Osborne, C. K.
    Schiff, R.
    CANCER RESEARCH, 2017, 77
  • [6] Identification of a high FOXA1-induced pro-metastatic enhancer signature in endocrine-resistant and metastatic breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    De Angelis, Carmine
    Nanda, Sarmistha
    Qin, Lanfang
    Veeraraghavan, Jamunarani
    Selenica, Pier
    Weigelt, Britta
    Reis-Filho, Jorge S.
    Nardone, Agostina
    Jeselsohn, Rinath
    Brown, Myles
    Rimawi, Mothaffar F.
    Osborne, Ckent
    Schiff, Rachel
    CANCER RESEARCH, 2020, 80 (04)
  • [7] Integrative cistromic/transcriptomic profiling identifies a high FOXA1/ER-activated pro-metastatic secretome in endocrine-resistant breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    De Angelis, Carmine
    Nanda, Sarmistha
    Qin, Lanfang
    Shea, Martin J.
    Mitchell, Tamika
    Veeraraghavan, Jamunarani
    Sethunath, Vidyalakshmi
    Gutierrez, Carolina
    Gyorffy, Balazs
    Cohen, Ofir
    Wagle, Nikhil
    Nardone, Agostina
    Jeselsohn, Rinath
    Brown, Myles
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    CANCER RESEARCH, 2020, 80 (04)
  • [8] A FOXA1/FRA1-centered transcriptional axis regulates interferon signaling in high FOXA1-associated endocrine-resistant and metastatic breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    Qin, Lanfang
    De Angelis, Carmine
    Nanda, Sarmistha
    Shea, Martin
    Nardone, Agostina
    Jeselsohn, Rinath
    Cohen, Ofir
    Wagle, Nikhil
    Rimawi, Mothaffar
    Osborne, C. Kent
    Schiff, Rachel
    CANCER RESEARCH, 2021, 81 (04)
  • [9] FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
    Fu, Xiaoyong
    Jeselsohn, Rinath
    Pereira, Resel
    Hollingsworth, Emporia F.
    Creighton, Chad J.
    Li, Fugen
    Shea, Martin
    Nardone, Agostina
    De Angelis, Carmine
    Heiser, Laura M.
    Anur, Pavana
    Wang, Nicholas
    Grasso, Catherine S.
    Spellman, Paul T.
    Griffith, Obi L.
    Tsimelzon, Anna
    Gutierrez, Carolina
    Huang, Shixia
    Edwards, Dean P.
    Trivedi, Meghana V.
    Rimawi, Mothaffar F.
    Lopez-Terrada, Dolores
    Hilsenbeck, Susan G.
    Gray, Joe W.
    Brown, Myles
    Osborne, C. Kent
    Schiff, Rachel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (43) : E6600 - E6609
  • [10] p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane
    Hélène Vanacker
    Isabelle Treilleux
    Camille Schiffler
    Ivan Bieche
    Mario Campone
    Anne Patsouris
    Monica Arnedos
    Paul H. Cottu
    Jean-Philippe Jacquin
    Florence Dalenc
    Antoine Pinton
    Nicolas Servant
    Valéry Attignon
    Etienne Rouleau
    Alain Morel
    François Legrand
    Marta Jimenez
    Fabrice Andre
    Thomas Bachelot
    British Journal of Cancer, 2024, 130 : 613 - 619
12